Fmr LLC Fibrogen Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Fmr LLC holds 314,689 shares of FGEN stock, worth $132,169. This represents 0.0% of its overall portfolio holdings.

Number of Shares

314,689

Previous 295,214 6.6%

Holding current value

$132,169

Previous $693,000 59.6%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.89 - $2.36 $17,332 - $45,961	19,475 Added 6.6%	314,689 $280,000
Q1 2024 May 13, 2024	SELL	$0.73 - $2.73 $33,533 - $125,405	-45,936 Reduced 13.47%	295,214 $693,000
Q4 2023 Feb 13, 2024	BUY	$0.38 - $0.91 $7,417 - $17,762	19,519 Added 6.07%	341,150 $303,000
Q3 2023 Nov 13, 2023	BUY	$0.79 - $2.83 $101,673 - $364,221	128,700 Added 66.71%	321,631 $276,000
Q2 2023 Aug 11, 2023	SELL	$2.49 - $20.59 $210,987 - $1.74 Million	-84,734 Reduced 30.52%	192,931 $520,000
Q1 2023 May 11, 2023	BUY	$15.95 - $25.18 $4.25 Million - $6.7 Million	266,238 Added 2329.9%	277,665 $5.18 Million
Q4 2022 Feb 13, 2023	SELL	$13.27 - $17.73 $841,118 - $1.12 Million	-63,385 Reduced 84.73%	11,427 $183,000
Q3 2022 Nov 10, 2022	BUY	$11.4 - $14.6 $4,537 - $5,810	398 Added 0.53%	74,812 $973,000
Q2 2022 Aug 12, 2022	SELL	$7.94 - $12.96 $3,501 - $5,715	-441 Reduced 0.59%	74,414 $786,000
Q1 2022 May 13, 2022	BUY	$12.02 - $16.79 $858,420 - $1.2 Million	71,416 Added 2076.65%	74,855 $900,000
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $7.7 Million - $11.9 Million	-775,183 Reduced 99.56%	3,439 $48,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $29.1 Million - $76 Million	-2,853,886 Reduced 78.57%	778,622 $7.96 Million
Q2 2021 Aug 13, 2021	BUY	$18.57 - $35.68 $67.5 Million - $130 Million	3,632,508 New	3,632,508 $96.7 Million

Others Institutions Holding FGEN

# of Institutions

115

Shares Held

57.5M

Call Options Held

2.14M

Put Options Held

907K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $39.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account